Core Viewpoint - Shineco, Inc. has announced a public offering of 1,869,160 shares of common stock at a price of 2 million before expenses [1]. Group 1: Offering Details - The public offering consists of 1,869,160 shares priced at 2 million [1]. - Underwriters have a 45-day option to purchase an additional 280,374 shares at the same public offering price [1]. - The offering is anticipated to close on July 15, 2024, pending customary closing conditions [1]. Group 2: Underwriting and Registration - EF Hutton LLC is serving as the sole book-running manager for the offering [2]. - The shares are being offered under an effective shelf registration statement filed with the SEC, which was declared effective on June 10, 2022 [2]. - A prospectus supplement detailing the terms of the offering will be filed with the SEC [2]. Group 3: Company Overview - Shineco, Inc. focuses on providing innovative diagnostic medical products and related medical devices, aiming to enhance the quality of life [4]. - The company has developed 33 vitro diagnostic reagents and related medical devices and also produces healthy and nutritious foods [4].
Shineco Announces Pricing of $2 Million Underwritten Public Offering